Dr Macleod is a Clinical Pharmacologist with a personal chair (Teaching and Research) at the University of Aberdeen and honorary Consultant Physician within NHS Grampian. Her clinical work is largely in the area of acute stroke management, hypertension clinics and primary and secondary cardiovascular prevention. Current research interests include:
Novel imaging markers in stroke and small vessel disease using fast field cycling MRI
Using linked datasets to explore management of stroke including service organisation and secondary prevention
Interactions between stroke and other diseases (e.g. cancer)
Chair of Scotland A and B Research Ethics Committees
Honorary Deputy Secretary, British and Irish Association of Stroke Physicians
Trustee SHARP (Scottish Heart and Arterial Disease Prevention)
Latest Publications
Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial
Muir, K. W., Ford, G. A., Ford, I., Wardlaw, J. M., McConnachie, A., Greenlaw, N., Mair, G., Sprigg, N., Price, C. I., MacLeod, M. J., Dima, S., Venter, M., Zhang, L., O’Brien, E., Sanyal, R., Reid, J., Sztriha, L. K., Haider, S., Whiteley, W. N., Kennedy, J., Perry, R., Lakshmanan, S., Chakrabarti, A., Hassan, A., Marigold, R., Raghunathan, S., Sims, D., Bhandari, M., Wiggam, I., Rashed, K., Douglass, C., ATTEST-2 Investigators
The Lancet neurology, vol. 23, no. 11, pp. 1087-1096
Randomised Trial of Tenecteplase versus Alteplase for Acute Stroke within 4.5h of onset: the second Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST-2)
Muir, K., Ford, G., Ford, I., Wardlaw, J., McConnachie, A., Greenlaw, N., Price, C. I., Macleod, M., Dima, S., Venter, M., Zhang, L., O’Brien, E., Sanyal, R., Reid, J., Sztriha, L., Haider, S., Whiteley, W. N., Kennedy, J., Perry, R., Sekaran, L., Chakrabarti, A., Hassan, A., Marigold, R., Raghunathan, S., Sims, D., Bhandari, M., Douglass, C., ATTEST-2 Investigators